AAAAAA

   
Results: 1-9 |
Results: 9
CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease
Authors: Engaras, B Kewenter, J Nilsson, O Wedel, H Hafstrom, L
Citation: B. Engaras et al., CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease, EUR J SUR O, 27(1), 2001, pp. 43-48
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types - Summary and conclusions
Authors: Glimelius, B Bergh, J Brandt, L Brorsson, B Gunnars, B Hafstrom, L Haglund, U Hogberg, T Janunger, KG Jonsson, PE Karlsson, G Kimby, E Lamnevik, G Nilsson, S Permert, J Ragnhammar, P Sorenson, S Nygren, P
Citation: B. Glimelius et al., The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types - Summary and conclusions, ACTA ONCOL, 40(2-3), 2001, pp. 135-154
A systematic overview of chemotherapy effects in colorectal cancer
Authors: Ragnhammar, P Hafstrom, L Nygren, P Glimelius, B
Citation: P. Ragnhammar et al., A systematic overview of chemotherapy effects in colorectal cancer, ACTA ONCOL, 40(2-3), 2001, pp. 282-308
A systematic overview of chemotherapy effects in gastric cancer
Authors: Janunger, KG Hafstrom, L Nygren, P Glimelius, B
Citation: Kg. Janunger et al., A systematic overview of chemotherapy effects in gastric cancer, ACTA ONCOL, 40(2-3), 2001, pp. 309-326
A systematic overview of chemotherapy effects in pancreatic cancer
Authors: Permert, J Hafstrom, L Nygren, P Glimelius, B
Citation: J. Permert et al., A systematic overview of chemotherapy effects in pancreatic cancer, ACTA ONCOL, 40(2-3), 2001, pp. 361-370
p53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection
Authors: Yang, Y Forslund, A Remotti, H Lonnroth, C Andersson, M Brevinge, H Svanberg, E Lindner, P Hafstrom, L Naredi, P Lundholm, K
Citation: Y. Yang et al., p53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection, CANCER, 91(4), 2001, pp. 727-736
Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA242 during twelve months in men and women aged 60-64 years without malignant disease
Authors: Engaras, B Hafstrom, L Kewenter, J Nilsson, O Wedel, H
Citation: B. Engaras et al., Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA242 during twelve months in men and women aged 60-64 years without malignant disease, EURO J SURG, 165(2), 1999, pp. 110-116
Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentretrial
Authors: Westman, G Bergman, B Albertsson, M Kadar, L Gustavsson, G Thaning, L Andersson, M Straumits, A Jeppson, B Linden, CJ Ewers, SB Andersson, H Mercke, C Hafstrom, L Birck, O Orgum, P
Citation: G. Westman et al., Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentretrial, EUR J CANC, 35(4), 1999, pp. 586-595
Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan
Authors: Lindner, P Fjalling, M Hafstrom, L Kierulff-Nielsen, H Mattsson, J Schersten, T Rizell, M Naredi, P
Citation: P. Lindner et al., Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan, EUR J SUR O, 25(2), 1999, pp. 179-185
Risultati: 1-9 |